A Prostate Cancer Specific Telomerase Repressor Region on Human Chromosome 11q_Crimson Publishers

 A Prostate Cancer Specific Telomerase Repressor Region on Human Chromosome 11q by Terry Roberts in Novel Approaches in Cancer Study


Abstract

Telomerase reactivation is one of the key events in the development of cancer. More than 90% of all cancers de-repress sequences within the genome, which results in the overexpression of hTERT and telomerase. In doing so, telomeres at the ends of human chromosomes, which would naturally shorten after each round of replication, are maintained indefinitely giving rise to immortalized cells. The actual mechanisms responsible for telomerase depression in cancer are still under intense investigation and the elucidation of this process would represent a major therapeutic target. The literature has pointed to genes on different chromosomes being responsible for telomerase repression in specific cancers. Microcell Mediated Chromosome Transfer (MMCT) was used to transfer human chromosomes 3, 8, 10, 11, 13, and 17 into the prostate cancer cell line PC3. In doing so, we observed robust and sustained hTERT and telomerase repression for chromosome 11. We then fragmented chromosome 11 using 25G of gamma radiation before repeating the transfer into PC3. We found that 70% of the hybrid clones picked expressed very low levels of hTERT and telomerase when compared to the controls. STS mapping of the clones identified 3 distinct regions on chromosome 11q which could harbour sequences responsible for telomerase repression specific to prostate cancer. Identification of this telomerase repressor could lead to new chemotherapeutic drugs to target prostate cancer or a highly specific biomarker for the disease.

Read more about this article:

https://crimsonpublishers.com/nacs/fulltext/NACS.000664.php 

For more articles in Novel Approaches in Cancer Study

https://crimsonpublishers.com/nacs/


Comments

Post a Comment

Popular posts from this blog

Recent Advances in the Therapeutic Approaches of Glioblastoma Multiforme_Crimson Publishers

Image
  Recent Advances in the Therapeutic Approaches of Glioblastoma Multiforme by Siddharth Shah in  in Novel Approaches in Cancer Study Abstract Glioblastoma Multiforme (GBM, WHO grade IV) is one of the most aggressive, invasive, and lethal intracranial neoplasms, with a low post-diagnosis survival rate. Standard-of-care treatment regimens involving maximal surgical resection, radiotherapy, and genetic anti-tumor compounds like Temozolomide have only been marginally effective in improving overall survival and quality of life. Cell fusion, autophagy, and other complex biological processes affecting GBM pathophysiology are being studied to improve GBM treatment. This paper therefore focuses on oncolytic virus therapy combined with surgical resection, photodynamic therapy, and novel gene therapy, demonstrating how GBM treatment for patients could result in immediate and authentic tumor cytotoxicity and removal, rather than treatment of recurrent GBM. Standard therapy for GBM,...
Read more

Release of Inorganic Phosphate into the Tumor Environment: Possible Roles of Ecto- Nucleotidases and Ecto-Phosphatases

Abstract Inorganic phosphate (Pi) is essential for several biochemical reaction. Serum Pi is maintained at relatively narrow range concentrations, between 0.7 and 1.55mM. Tumor microenvironment presents a high Pi concentration (1.8±0.2mM Pi) and this could be associated wi the rapid growth in the “Growth Rate Hypothesis”. Several studies have identified high expression of Pi transporters in various tumor tissues. Similarly, ecto-enzymes (like ecto-nucleotidases or ecto- phosphates) act by dephosphorylating phosphosubstrates in the extracellular environment, and its high expression has been observed in various types of cancer. Little is known about the function of these ecto-enzymes on Pi releasing and accumulation in the tumor environment. Therefore, the purpose of this study is to correlate a possible contribution of the Pi release in the tumor microenvironment by ecto-nucleotidases and ecto-phosphatases, concomitant to the regulation of Pi extracellular pool by specific Pi...
Read more

Release of Inorganic Phosphate into the Tumor Environment: Possible Roles of Ecto- Nucleotidases and Ecto-Phosphatases_Crimson Publishers

Image
Release of Inorganic Phosphate into the Tumor Environment: Possible Roles of Ecto- Nucleotidases and Ecto-Phosphatases by Marco Antonio Lacerda-Abreu and José Roberto Meyer- Fernandes in Journal of Cancer Research Crimson Publishers _  Novel Approaches in Cancer Study Inorganic phosphate (Pi) is essential for several biochemical reaction. Serum Pi is maintained at relatively narrow range concentrations, between 0.7 and 1.55mM. Tumor microenvironment presents a high Pi concentration (1.8±0.2mM Pi) and this could be associated wi the rapid growth in the “Growth Rate Hypothesis”. Several studies have identified high expression of Pi transporters in various tumor tissues. Similarly, ecto-enzymes (like ecto-nucleotidases or ecto- phosphates) act by dephosphorylating phosphosubstrates in the extracellular environment, and its high expression has been observed in various types of cancer. Little is known about the function of these ecto-enzymes on Pi releasing and accumulation in the tu...
Read more